KIAA1199, a deafness gene of unknown function, is a new hyaluronan binding protein involved in hyaluronan depolymerization

Hiroyuki Yoshida, Aya Nagaoka, Ayumi Kusaka-Kikushima, Megumi Tobiishi, Keigo Kawabata, Tetsuya Sayo, Shingo Sakai, Yoshinori Sugiyama, Hiroyuki Enomoto, Yasunori Okada, Shintaro Inoue

Research output: Contribution to journalArticle

93 Citations (Scopus)

Abstract

Hyaluronan (HA) has an extraordinarily high turnover in physiological tissues, and HA degradation is accelerated in inflammatory and neoplastic diseases. CD44 (a cell surface receptor) and two hyaluronidases (HYAL1 and HYAL2) are thought to be responsible for HA binding and degradation; however, the role of these molecules in HA catabolism remains controversial. Here we show that KIAA1199, a deafness gene of unknown function, plays a central role in HA binding and depolymerization that is independent of CD44 and HYAL enzymes. The specific binding of KIAA1199 to HA was demonstrated in glycosaminoglycan-binding assays. We found that knockdown of KIAA1199 abolished HA degradation by human skin fibroblasts and that transfection of KIAA1199 cDNA into cells conferred the ability to catabolize HA in an endo-β-N-acetylglucosaminidase- dependent manner via the clathrin-coated pit pathway. Enhanced degradation of HA in synovial fibroblasts from patients with osteoarthritis or rheumatoid arthritis was correlated with increased levels of KIAA1199 expression and was abrogated by knockdown of KIAA1199. The level of KIAA1199 expression in uninflamed synovium was less than in osteoarthritic or rheumatoid synovium. These data suggest that KIAA1199 is a unique hyaladherin with a key role in HA catabolism in the dermis of the skin and arthritic synovium.

Original languageEnglish
Pages (from-to)5612-5617
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume110
Issue number14
DOIs
Publication statusPublished - 2013 Apr 2

Fingerprint

CD44 Antigens
Deafness
Hyaluronic Acid
Genes
Synovial Membrane
Fibroblasts
Acetylglucosaminidase
Clathrin
Skin
Hyaluronoglucosaminidase
Cell Surface Receptors
Dermis
Glycosaminoglycans
Osteoarthritis
Arthritis
Transfection
Rheumatoid Arthritis
Complementary DNA

Keywords

  • Extracellular matrix
  • Hearing loss
  • Hyaluronate
  • Hyaluronic acid

ASJC Scopus subject areas

  • General

Cite this

KIAA1199, a deafness gene of unknown function, is a new hyaluronan binding protein involved in hyaluronan depolymerization. / Yoshida, Hiroyuki; Nagaoka, Aya; Kusaka-Kikushima, Ayumi; Tobiishi, Megumi; Kawabata, Keigo; Sayo, Tetsuya; Sakai, Shingo; Sugiyama, Yoshinori; Enomoto, Hiroyuki; Okada, Yasunori; Inoue, Shintaro.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 110, No. 14, 02.04.2013, p. 5612-5617.

Research output: Contribution to journalArticle

Yoshida, H, Nagaoka, A, Kusaka-Kikushima, A, Tobiishi, M, Kawabata, K, Sayo, T, Sakai, S, Sugiyama, Y, Enomoto, H, Okada, Y & Inoue, S 2013, 'KIAA1199, a deafness gene of unknown function, is a new hyaluronan binding protein involved in hyaluronan depolymerization', Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 14, pp. 5612-5617. https://doi.org/10.1073/pnas.1215432110
Yoshida, Hiroyuki ; Nagaoka, Aya ; Kusaka-Kikushima, Ayumi ; Tobiishi, Megumi ; Kawabata, Keigo ; Sayo, Tetsuya ; Sakai, Shingo ; Sugiyama, Yoshinori ; Enomoto, Hiroyuki ; Okada, Yasunori ; Inoue, Shintaro. / KIAA1199, a deafness gene of unknown function, is a new hyaluronan binding protein involved in hyaluronan depolymerization. In: Proceedings of the National Academy of Sciences of the United States of America. 2013 ; Vol. 110, No. 14. pp. 5612-5617.
@article{b951f26c353a49e5b0a750eeffe07d13,
title = "KIAA1199, a deafness gene of unknown function, is a new hyaluronan binding protein involved in hyaluronan depolymerization",
abstract = "Hyaluronan (HA) has an extraordinarily high turnover in physiological tissues, and HA degradation is accelerated in inflammatory and neoplastic diseases. CD44 (a cell surface receptor) and two hyaluronidases (HYAL1 and HYAL2) are thought to be responsible for HA binding and degradation; however, the role of these molecules in HA catabolism remains controversial. Here we show that KIAA1199, a deafness gene of unknown function, plays a central role in HA binding and depolymerization that is independent of CD44 and HYAL enzymes. The specific binding of KIAA1199 to HA was demonstrated in glycosaminoglycan-binding assays. We found that knockdown of KIAA1199 abolished HA degradation by human skin fibroblasts and that transfection of KIAA1199 cDNA into cells conferred the ability to catabolize HA in an endo-β-N-acetylglucosaminidase- dependent manner via the clathrin-coated pit pathway. Enhanced degradation of HA in synovial fibroblasts from patients with osteoarthritis or rheumatoid arthritis was correlated with increased levels of KIAA1199 expression and was abrogated by knockdown of KIAA1199. The level of KIAA1199 expression in uninflamed synovium was less than in osteoarthritic or rheumatoid synovium. These data suggest that KIAA1199 is a unique hyaladherin with a key role in HA catabolism in the dermis of the skin and arthritic synovium.",
keywords = "Extracellular matrix, Hearing loss, Hyaluronate, Hyaluronic acid",
author = "Hiroyuki Yoshida and Aya Nagaoka and Ayumi Kusaka-Kikushima and Megumi Tobiishi and Keigo Kawabata and Tetsuya Sayo and Shingo Sakai and Yoshinori Sugiyama and Hiroyuki Enomoto and Yasunori Okada and Shintaro Inoue",
year = "2013",
month = "4",
day = "2",
doi = "10.1073/pnas.1215432110",
language = "English",
volume = "110",
pages = "5612--5617",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "14",

}

TY - JOUR

T1 - KIAA1199, a deafness gene of unknown function, is a new hyaluronan binding protein involved in hyaluronan depolymerization

AU - Yoshida, Hiroyuki

AU - Nagaoka, Aya

AU - Kusaka-Kikushima, Ayumi

AU - Tobiishi, Megumi

AU - Kawabata, Keigo

AU - Sayo, Tetsuya

AU - Sakai, Shingo

AU - Sugiyama, Yoshinori

AU - Enomoto, Hiroyuki

AU - Okada, Yasunori

AU - Inoue, Shintaro

PY - 2013/4/2

Y1 - 2013/4/2

N2 - Hyaluronan (HA) has an extraordinarily high turnover in physiological tissues, and HA degradation is accelerated in inflammatory and neoplastic diseases. CD44 (a cell surface receptor) and two hyaluronidases (HYAL1 and HYAL2) are thought to be responsible for HA binding and degradation; however, the role of these molecules in HA catabolism remains controversial. Here we show that KIAA1199, a deafness gene of unknown function, plays a central role in HA binding and depolymerization that is independent of CD44 and HYAL enzymes. The specific binding of KIAA1199 to HA was demonstrated in glycosaminoglycan-binding assays. We found that knockdown of KIAA1199 abolished HA degradation by human skin fibroblasts and that transfection of KIAA1199 cDNA into cells conferred the ability to catabolize HA in an endo-β-N-acetylglucosaminidase- dependent manner via the clathrin-coated pit pathway. Enhanced degradation of HA in synovial fibroblasts from patients with osteoarthritis or rheumatoid arthritis was correlated with increased levels of KIAA1199 expression and was abrogated by knockdown of KIAA1199. The level of KIAA1199 expression in uninflamed synovium was less than in osteoarthritic or rheumatoid synovium. These data suggest that KIAA1199 is a unique hyaladherin with a key role in HA catabolism in the dermis of the skin and arthritic synovium.

AB - Hyaluronan (HA) has an extraordinarily high turnover in physiological tissues, and HA degradation is accelerated in inflammatory and neoplastic diseases. CD44 (a cell surface receptor) and two hyaluronidases (HYAL1 and HYAL2) are thought to be responsible for HA binding and degradation; however, the role of these molecules in HA catabolism remains controversial. Here we show that KIAA1199, a deafness gene of unknown function, plays a central role in HA binding and depolymerization that is independent of CD44 and HYAL enzymes. The specific binding of KIAA1199 to HA was demonstrated in glycosaminoglycan-binding assays. We found that knockdown of KIAA1199 abolished HA degradation by human skin fibroblasts and that transfection of KIAA1199 cDNA into cells conferred the ability to catabolize HA in an endo-β-N-acetylglucosaminidase- dependent manner via the clathrin-coated pit pathway. Enhanced degradation of HA in synovial fibroblasts from patients with osteoarthritis or rheumatoid arthritis was correlated with increased levels of KIAA1199 expression and was abrogated by knockdown of KIAA1199. The level of KIAA1199 expression in uninflamed synovium was less than in osteoarthritic or rheumatoid synovium. These data suggest that KIAA1199 is a unique hyaladherin with a key role in HA catabolism in the dermis of the skin and arthritic synovium.

KW - Extracellular matrix

KW - Hearing loss

KW - Hyaluronate

KW - Hyaluronic acid

UR - http://www.scopus.com/inward/record.url?scp=84875847265&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875847265&partnerID=8YFLogxK

U2 - 10.1073/pnas.1215432110

DO - 10.1073/pnas.1215432110

M3 - Article

C2 - 23509262

AN - SCOPUS:84875847265

VL - 110

SP - 5612

EP - 5617

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 14

ER -